1. Home
  2. LUNG vs ULBI Comparison

LUNG vs ULBI Comparison

Compare LUNG & ULBI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Pulmonx Corporation

LUNG

Pulmonx Corporation

HOLD

Current Price

$2.53

Market Cap

97.1M

Sector

Health Care

ML Signal

HOLD

Logo Ultralife Corporation

ULBI

Ultralife Corporation

SELL

Current Price

$15.65

Market Cap

104.3M

Sector

Miscellaneous

ML Signal

SELL

Company Overview

Basic Information
Metric
LUNG
ULBI
Founded
1995
1990
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Specialties
Industrial Machinery/Components
Sector
Health Care
Miscellaneous
Exchange
Nasdaq
Nasdaq
Market Cap
97.1M
104.3M
IPO Year
2020
1995

Fundamental Metrics

Financial Performance
Metric
LUNG
ULBI
Price
$2.53
$15.65
Analyst Decision
Buy
Analyst Count
5
0
Target Price
★ $3.70
N/A
AVG Volume (30 Days)
★ 279.2K
23.0K
Earning Date
10-27-2026
11-17-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 7.64
N/A
EPS
N/A
★ 13.00
Revenue
$90,497,000.00
★ $191,159,000.00
Revenue This Year
$0.06
$17.65
Revenue Next Year
$8.58
N/A
P/E Ratio
★ N/A
$0.48
Revenue Growth
8.01
★ 16.24
52 Week Low
$1.13
$4.90
52 Week High
$2.66
$8.25

Technical Indicators

Market Signals
Indicator
LUNG
ULBI
Relative Strength Index (RSI) 77.09 93.46
Support Level $1.20 $5.79
Resistance Level N/A N/A
Average True Range (ATR) 0.13 0.25
MACD 0.07 0.60
Stochastic Oscillator 85.71 99.74

Price Performance

Historical Comparison
LUNG
ULBI

About LUNG Pulmonx Corporation

Pulmonx Corp is a commercial-stage medical technology company that provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease (COPD). solution, which is comprised of the Zephyr Endobronchial Valve (Zephyr Valve), the Chartis Pulmonary Assessment System (Chartis System), and the LungTraX Platform, is designed to treat severe emphysema patients who, despite medical management, are still profoundly symptomatic and either do not want or are ineligible for surgical approaches. The majority of the company's revenue is generated from the provision of cloud hosting and management services. The company geographically, operates in the USA, the EMEA, the Asia Pacific, and other international regions, the majority of revenue from USA.

About ULBI Ultralife Corporation

Ultralife Corp provides products and services ranging from power solutions to communications and electronics systems to customers across the globe in the government and defense, medical, safety and security, energy, and industrial sectors. The company also designs, manufactures, installs, and maintains power and communications systems including rechargeable and non-rechargeable batteries, charging systems, communications and electronics systems and accessories, and custom-engineered systems. The company's segments include Battery and Energy Products, and Communications Systems. It generates maximum revenue from the Battery and Energy Products segment, and from the U.S. The Battery & Energy Products segment includes Lithium 9-volt, cylindrical, and various other non-rechargeable batteries.

Share on Social Networks: